Lymphatic Education & Research Network Inc Le&rn is located in New York, NY. The organization was established in 1999. According to its NTEE Classification (H90) the organization is classified as: Medical Disciplines Research, under the broad grouping of Medical Research and related organizations. As of 12/2023, Lymphatic Education & Research Network Inc Le&rn employed 10 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Lymphatic Education & Research Network Inc Le&rn is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Lymphatic Education & Research Network Inc Le&rn generated $1.5m in total revenue. This organization has experienced exceptional growth, as over the past 8 years, it has increased revenue by an average of 11.1% each year . All expenses for the organization totaled $1.7m during the year ending 12/2023. While expenses have increased by 8.2% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE ORGANIZATION'S MISSION IS TO FIGHT LYMPHATIC DISEASE AND LYMPHEDEMA THROUGH EDUCATION, RESEARCH AND ADVOCACY. THE ORGANIZATION SEEKS TO ACCELERATE THE PREVENTION, TREATMENT, AND CURE OF LYMPHATIC DISEASES WHILE BRINGING PATIENTS AND MEDICAL PROFESSIONALS TOGETHER TO ADDRESS THE UNMET NEEDS SURROUNDING LYMPHATIC DISORDERS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
SOME ACTIVITIES OF THE ORGANIZATION DURING 2023 INCLUDED THE FOLLOWING: LE&RN CONTINUED TO EXPAND PROGRAMS TO MEET THE GOALS OF THE EXPANDED MISSION OF FIGHTING LYMPHATIC DISEASE THROUGH EDUCATION, RESEARCH, AND ADVOCACY. LE&RN CONTINUED THE INTERNATIONAL LYMPHATIC DISEASE AND LYMPHEDEMA REGISTRY, A NATIONAL PATIENT REGISTRY, TO STIMULATE RESEARCH AND SUPPORT CLINICAL TRIALS AND DRUG DEVELOPMENT. LE&RN CONTINUED THE INTERNATIONAL LYMPHATIC DISEASE AND LYMPHEDEMA BIOREPOSITORY, PROVIDING BIOLOGICAL MATERIALS TO SERVE AS A SOURCE FOR THE CLINICAL AND LABORATORY STUDY OF LYMPHATIC DISEASES, AND BEGAN SHARING DATA WITH WORLDWIDE DATABASES. LE&RN CONTINUED ITS GRANT PROGRAM THAT ALLOWS YOUNG INVESTIGATORS TO ATTEND A CONFERENCE FOCUSED ON LYMPHATIC RESEARCH. LE&RN CONTINUED ITS EDUCATIONAL AND AWARENESS OUTREACH PROGRAMS TARGETING ACADEMIA, GOVERNMENT, INDUSTRY, AND THE MEDICAL AND PATIENT COMMUNITIES. LE&RN CONTINUED ITS MONTHLY VIRTUAL SYMPOSIUM SERIES, WHICH BRINGS THE WORLD'S FOREMOST AUTHORITIES IN LYMPHATIC DISEASE AND LYMPHEDEMA TO PATIENTS, THEIR FAMILIES, AND PROFESSIONALS. LE&RN UPDATED ITS WEBSITE AND PROVIDED DAILY SOCIAL MEDIA POSTS AND MONTHLY NEWSLETTERS FEATURING SIGNIFICANT EVENTS IN THE FIELD. LE&RN PRODUCED SIX ISSUES OF LYMPHATIC RESEARCH AND BIOLOGY, AN INTERNATIONAL, PEER-REVIEWEDBIOMEDICAL JOURNAL PROVIDING A FORUM FOR THE EXCHANGE OF CUTTING-EDGE SCIENTIFIC DEVELOPMENTS IN LYMPHATIC SCIENCE AND MEDICINE. LE&RN SECURED ONGOING SUPPORT FROM THE CONGRESSIONAL AND NATIONAL INSTITUTES OF HEALTH FOR LYMPHATIC RESEARCH. LE&RN CONTINUED THE LE&RN/LYMPHNOTES LYMPHEDEMA SCHOLARSHIP PROGRAM TO PROVIDE TUITION SUPPORT TO THERAPISTS SEEKING CERTIFICATION IN LYMPHEDEMA THERAPY LE&RN CONTINUED A WEB-BASED "ASK THE EXPERTS" FEATURE THAT ALLOWS PATIENTS, THEIR FAMILIES, AND PROFESSIONALS TO ASK THE MOST PROMINENT AUTHORITIES IN THE FIELD QUESTIONS DIRECTLY. LE&RN SPOKESPERSON AND ACADEMY AWARD WINNER KATHY BATES APPEARED IN PRINT AND TELEVISION MEDIA TO SUPPORT RESEARCH. LE&RN GREW ITS HONORARY BOARD, HEADED BY KATHY BATES AND INCLUDING NOTABLE CELEBRITIES WHO SUPPORT LE&RN'S MISSION. LE&RN'S VIRTUAL EXPO WAS EXPANDED TO BETTER SERVE PATIENTS AND THERAPISTS. LE&RN AND NAVBO PREPARED A BIENNIAL VIRTUAL LYMPHATIC FORUM FOR RESEARCHERS LE&RN DEVELOPED NEW CHAPTERS IN SEVERAL STATES AND COUNTRIES. LE&RN CONTINUED TO LEAD GLOBAL EVENTS RELATED TO ITS HAVING ESTABLISHED WORLD LYMPHEDEMA DAY ON MARCH 6, 2016. LE&RN HOSTED A NATIONAL ACTION WEEK SUPPORTING THE CREATION OF A NATIONAL COMMISSION ON LYMPHATIC DISEASES. LE&RN SUPPORTED AND GREW ITS PROGRAM, CREATING THE FIRST-EVER CENTERS OF EXCELLENCE IN THE DIAGNOSIS & TREATMENT OF LYMPHATIC DISEASES. LE&RN, IN COLLABORATION WITH STANFORD UNIVERSITY, HOSTED THE ANNUAL VIRTUAL STATE-OF-THE-ART SUMMIT IN LYMPHATIC RESEARCH & MEDICINE. LE&RN PROMOTED ITS AUTHORED NEW YORK STATE BILL THAT MANDATES HOSPITAL INSTITUTIONS TO PROVIDE LYMPHEDEMA MATERIALS TO ALL AT-RISK PATIENTS. LE&RN PROMOTED ITS PSA VIDEO FEATURING NATIONAL SPOKESPERSON KATHY BATES, HOSTED ON THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) CANCER-RELATED WEBSITES. LE&RN CONTINUED ITS CANCER-RELATED LYMPHEDEMA CAMPAIGN FUNDED BY A GRANT FROM THE CDC CHRONIC DISEASE AWARENESS GRANTS PROGRAM. STAVROS NIARCHOS FOUNDATION CONTINUED ITS LE&RN GRANT TO FUND ITS CENTERS OF EXCELLENCE PROGRAM. LE&RN SUCCEEDED IN ITS EFFORTS TO HAVE THE CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAM (CDMRP) INCLUDE LYMPHEDEMA AND LYMPHATIC DISEASES AS CATEGORIES IN THE DEPARTMENT OF DEFENSE'S PEER REVIEWED MEDICAL RESEARCH PROGRAM (PRMRP). LE&RN SUCCEEDED IN ITS EFFORTS TO HAVE CONGRESS REQUEST THAT THE NATIONAL INSTITUTES OF HEALTH (NIH) ESTABLISH A NATIONAL COMMISSION ON LYMPHATIC DISEASES. LE&RN ESTABLISHED A GLOBAL PATIENT RESOURCE CENTER. LE&RN EXPANDED AND UPDATED ITS GLOBAL PATIENT REGISTRY. LE&RN CREATED THE CDC'S FIRST NATIONAL INDICATOR REPORT ON CANCER-RELATED LYMPHEDEMA. LE&RN SUCCESSFULLY ADVOCATED FOR A PROGRAM MANAGER IN LYMPHATICS AT THE ADVANCED RESEARCH AGENCY FOR HEALTH (ARPA-H) LE&RN CREATED A "GAPS IN LYMPHATIC RESEARCH" DOCUMENT IN CONCERT WITH THE RESEARCH COMMUNITY, DISTRIBUTED TO NIH, CDC, ARPA-H, CDMRP, NNLBI, AND NIAID.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Joseph Dayan MD Director | Trustee | 1 | $0 |
Doron Ilan MD Director | Trustee | 1 | $0 |
Dave Mcdowell Chairperson | OfficerTrustee | 10 | $0 |
Rick Petty Director | Trustee | 1 | $0 |
Name Not Listed Treasurer | 1 | $0 | |
Name Not Listed Secretary | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $522,491 |
All other contributions, gifts, grants, and similar amounts not included above | $868,557 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $1,391,048 |
Total Program Service Revenue | $0 |
Investment income | $48,778 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $36,539 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $1,476,365 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $17,000 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $272,913 |
Compensation of current officers, directors, key employees. | $27,291 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $453,812 |
Pension plan accruals and contributions | $30,000 |
Other employee benefits | $99,865 |
Payroll taxes | $50,513 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $42,600 |
Fees for services: Lobbying | $62,356 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $0 |
Office expenses | $6,503 |
Information technology | $19,467 |
Royalties | $0 |
Occupancy | $29,833 |
Travel | $26,587 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $4,422 |
All other expenses | $5,735 |
Total functional expenses | $1,736,198 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $688,563 |
Savings and temporary cash investments | $209,493 |
Pledges and grants receivable | $22,500 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $9,897 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $2,896,943 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $778 |
Total assets | $3,828,174 |
Accounts payable and accrued expenses | $72,297 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $285,104 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $357,401 |
Net assets without donor restrictions | $3,353,875 |
Net assets with donor restrictions | $116,898 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $3,828,174 |